Chris Frates On Power, People And Influence From Capitol Hill To K Street

Study: Drug, Medical Device Industries Spending Big on Lobbying

A new analysis shows pharmaceutical companies and their trade groups dropped more than $487 million on lobbying from 2009 through 2011. Biotechnology firms and their trade associations, meanwhile, spent more than $126 million on lobbying and medical device manufacturers and their trade groups paid out over $86 million for lobbying, the analysis found.

The analysis, with data compiled by the Center for Responsive Politics and commissioned by the Union of Concerned Scientists, also found that these industries gave about $6.3 million in campaign contributions to 70 lawmakers serving on relevant committees.


Leave A Comment
The National Journal Group has the right (but not the obligation) to monitor the comments and to remove any materials it deems inappropriate.
Comments powered by Disqus
Follow National Journal
About Influence Alley

Editor and Chief Contributor: Chris Frates
Deputy Editor: Michael Catalini
Reporter: Elahe Izadi
Contributors: John Aloysius Farrell, Shane Goldmacher, Billy House, Ben Terris